Cytopathic SARS-CoV-2 screening on VERO-E6 cells in a large-scale repurposing effort

Worldwide, there are intensive efforts to identify repurposed drugs as potential therapies against SARS-CoV-2 infection and the associated COVID-19 disease. To date, the anti-inflammatory drug dexamethasone and (to a lesser extent) the RNA-polymerase inhibitor remdesivir have been shown to be effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaliani, Andrea, Vangeel, Laura, Reinshagen, Jeanette, Iaconis, Daniela, Kuzikov, Maria, Keminer, Oliver, Wolf, Markus, Ellinger, Bernhard, Esposito, Francesca, Corona, Angela, Tramontano, Enzo, Manelfi, Candida, Herzog, Katja, Jochmans, Dirk, De Jonghe, Steven, Chiu, Winston, Francken, Thibault, Schepers, Joost, Collard, Caroline, Abbasi, Kayvan, Claussen, Carsten, Summa, Vincenzo, Beccari, Andrea R., Neyts, Johan, Gribbon, Philip, Leyssen, Pieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Data Descriptor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279437/
https://www.ncbi.nlm.nih.gov/pubmed/35831315
http://dx.doi.org/10.1038/s41597-022-01532-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279437/
https://www.ncbi.nlm.nih.gov/pubmed/35831315
http://dx.doi.org/10.1038/s41597-022-01532-x

Ejemplares similares